Calculators

401k Retirement Calculator Mortgage Calculator

New

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Smart Portfolio Expert Center TipRanksAI

TOOLS

Daily Analyst Ratings

STOCKS

ADVANCED RESEARCH

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TSE:DMT

Press ReleasesSmall Pharma Reports Fiscal Second Quarter 2024 Highlights

7M ago

DMT

PremiumPress Releases

Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders

7M ago

DMT

PremiumPress Releases

Disposition of Common Shares of Small Pharma Inc.

7M ago

DMT

PremiumPress Releases

Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder

7M ago

DMT

PremiumPress Releases

Small Pharma Reports Fiscal First Quarter 2024 Highlights

9M ago

DMT

PremiumPress ReleasesSmall Pharma Announces SPL028 R&D Strategy Update

10M ago

DMT

PremiumPress Releases

Small Pharma Announces Management Team Change

10M ago

DMT

PremiumPress Releases

Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights

10M ago

DMT

PremiumPre-Earnings

DMT Upcoming Earnings Report: What to Expect?

11M ago

DMT

PremiumPress Releases

Small Pharma Announces Significant Developments In Intellectual Property Portfolio

12M ago

DMT

PremiumPress Releases

Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology

1y ago

DMT

PremiumPress Releases

Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

1y ago

DMT

PremiumPress ReleasesSmall Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

1y ago

DMT

PremiumPress Releases

Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results

1y ago

DMT

PremiumPress Releases

Small Pharma to Present at Cowen’s 43rd Annual Health Care Conference

1y ago

DMT

PremiumPress Releases

First Subject Dosed in Small Pharma’s First-in-Human Phase I Clinical Trial with SPL028

1y ago

DMT

PremiumPress Releases

Small Pharma Announces Update on Intellectual Property Portfolio with Two New Patents Approved for Issue

1y ago

DMT

PremiumPress Releases

Small Pharma Reports Fiscal Third Quarter 2023 Highlights

1y ago

DMT

PremiumPress Releases

Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder

1y ago

DMT

Small Pharma To Announce Results of SPL026 Phase IIa Trial for Major Depressive Disorder and Host Conference Call on Wednesday, January 25

PremiumPress ReleasesSmall Pharma To Announce Results of SPL026 Phase IIa Trial for Major Depressive Disorder and Host Conference Call on Wednesday, January 25

1y ago

DMT

PremiumPress Releases

First Patient Dosed in Small Pharma’s Phase I Study Exploring Intramuscular Administration of SPL026

1y ago

DMT

PremiumPress Releases

Small Pharma Announces Completion of SPL026 Phase IIa Trial and Secures New Intellectual Property

1y ago

DMT

TSE:DMT

Trending

Indices

Stocks

ETFs